Decision: Favourable
Study Title:
CONNected Electronic Inhalers Asthma Control Trial 3 (CONNECT 3), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optim
NREC Code:
22-NREC-MD-027
Decision:
Favourable
Meeting Date:
15/09/2022
Study Type:
MD application
Principal Investigator:
Prof. Richard Costello
PI Institution:
Beaumont Hospital
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.